Crescent Biopharma (CBIO) Research & Development (2013 - 2026)
Crescent Biopharma (CBIO) reported Research & Development of $17.9 million for Q1 2026, up 68.47% year-over-year from $10.6 million in Q1 2025, and down 77.11% quarter-over-quarter from $78.2 million in Q4 2025.
Crescent Biopharma (CBIO) Research & Development (2013 - 2026) Analysis & Trends
Crescent Biopharma (CBIO) has 14 years of Research & Development data on file, last reported at $17.9 million in Q1 2026.
- Research & Development for Q1 2026 came in at $17.9 million, up 68.47% year-over-year; the trailing twelve-month figure through Mar 2026 was $128.5 million (up 557.93% YoY), and the FY2025 annual result was $138.1 million, up 868.36% from the prior year.
- Research & Development fell to $17.9 million in Q1 2026 per CBIO's latest filing, from $78.2 million in the prior quarter.
- Over five years, Research & Development peaked at $78.2 million in Q4 2025 and troughed at $150000.0 in Q4 2024.
- A 5-year average of $11.9 million and a median of $6.0 million in 2024 frame the typical range for Research & Development.
- The sharpest annual moves came in 2024 and 2025: Research & Development plunged 97.16% in 2024, then soared 52033.33% in 2025.
- A 5-year view of Research & Development shows it stood at $5.9 million in 2022, then dropped by 10.23% to $5.3 million in 2023, then sank by 97.16% to $150000.0 in 2024, then soared by 52033.33% to $78.2 million in 2025, then sank by 77.11% to $17.9 million in 2026.
- Business Quant data shows CBIO's Research & Development at $17.9 million in Q1 2026, $78.2 million in Q4 2025, and $20.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 4.32 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 15.66 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 626,092.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -101.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -2.30 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 1.46 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 357,444.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 961.60 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -58.00 Mn |
| 10 | Crescent Biopharma | 486.92 Mn | 297.76 Mn | - | 17.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.90 Mn |
| Dec 31, 2025 | 78.20 Mn |
| Sep 30, 2025 | 20.35 Mn |
| Jun 30, 2025 | 12.08 Mn |
| Mar 31, 2025 | 10.63 Mn |
| Dec 31, 2024 | 150,000.00 |
| Sep 30, 2024 | 2.47 Mn |
| Jun 30, 2024 | 6.29 Mn |
| Mar 31, 2024 | 6.03 Mn |
| Dec 31, 2023 | 5.29 Mn |
| Sep 30, 2023 | 5.29 Mn |
| Jun 30, 2023 | 4.07 Mn |
| Mar 31, 2023 | 5.42 Mn |
| Dec 31, 2022 | 5.89 Mn |
| Sep 30, 2022 | 4.92 Mn |
| Jun 30, 2022 | 7.97 Mn |
| Mar 31, 2022 | 9.60 Mn |
| Dec 31, 2021 | 12.90 Mn |
| Sep 30, 2021 | 13.28 Mn |
| Jun 30, 2021 | 10.17 Mn |